Craft

Lombard Medical

Stock Price

$0

2024-10-29

Market Capitalization

$265.5 K

2024-10-29

Revenue

£2.9 M

FY, 2014

Lombard Medical Summary

Company Summary

Overview
Lombard Medical, Inc. is a medical device company focused on minimally invasive treatment of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. The Company has also achieved CE Mark for the Altura endograft system, an ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA anatomies.
Type
Public
Status
Active
HQ
Oxfordshire, GB | view all locations
Website
http://www.lombardmedical.com/
Cybersecurity rating
Sectors

LocationsView all

3 locations detected

  • Oxfordshire, England HQ

    United Kingdom

    4 Lombard Medical House Trident Park

  • Irvine, CA

    United States

    6440 Oak Canyon #200

  • Augsburg, BY

    Germany

    Werner-Haas-Straße 8

Lombard Medical Financials

Summary Financials

Net income (FY, 2016)
(£4.8M)
Cash (FY, 2016)
£849.0K
EBIT (FY, 2016)
(£4.7M)

Footer menu